ZA961749B - The pharmacological use of certain cystine derivatives - Google Patents

The pharmacological use of certain cystine derivatives

Info

Publication number
ZA961749B
ZA961749B ZA961749A ZA961749A ZA961749B ZA 961749 B ZA961749 B ZA 961749B ZA 961749 A ZA961749 A ZA 961749A ZA 961749 A ZA961749 A ZA 961749A ZA 961749 B ZA961749 B ZA 961749B
Authority
ZA
South Africa
Prior art keywords
pharmacological use
cystine derivatives
certain
certain cystine
derivatives
Prior art date
Application number
ZA961749A
Other languages
English (en)
Inventor
Hakan Bergstrand
Knut Pettersson
Christer Westerlund
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Publication of ZA961749B publication Critical patent/ZA961749B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/223—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of alpha-aminoacids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/225—Polycarboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Emergency Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
ZA961749A 1995-03-14 1996-03-04 The pharmacological use of certain cystine derivatives ZA961749B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9500897A SE9500897D0 (sv) 1995-03-14 1995-03-14 The pharmacological use of certain cystine derivatives

Publications (1)

Publication Number Publication Date
ZA961749B true ZA961749B (en) 1996-09-16

Family

ID=20397536

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA961749A ZA961749B (en) 1995-03-14 1996-03-04 The pharmacological use of certain cystine derivatives

Country Status (24)

Country Link
US (1) US5883126A (cs)
EP (1) EP0814798A1 (cs)
JP (1) JPH11501916A (cs)
KR (1) KR19980703055A (cs)
CN (1) CN1183718A (cs)
AR (1) AR002716A1 (cs)
AU (1) AU701287B2 (cs)
BR (1) BR9607225A (cs)
CA (1) CA2214831A1 (cs)
CZ (1) CZ288219B6 (cs)
EE (1) EE03382B1 (cs)
HU (1) HUP9801985A3 (cs)
IL (1) IL117465A (cs)
IS (1) IS4554A (cs)
NO (1) NO974143L (cs)
NZ (1) NZ303781A (cs)
PL (1) PL183234B1 (cs)
SE (1) SE9500897D0 (cs)
SK (1) SK282448B6 (cs)
TR (1) TR199700945T1 (cs)
TW (1) TW385249B (cs)
UA (1) UA42830C2 (cs)
WO (1) WO1996028149A1 (cs)
ZA (1) ZA961749B (cs)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6007819A (en) * 1995-10-17 1999-12-28 Dovetail Technologies, Inc. Methods of inducing immunity using low molecular weight immune stimulants
DE19821625C1 (de) * 1998-05-15 2000-01-05 Merck Patent Gmbh Pharmazeutische Zubereitung
SE9900438D0 (sv) * 1999-02-10 1999-02-10 Astra Ab The pharmacological use of certian cystine derivatives

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR8205M (cs) * 1968-12-20 1970-09-14
US3878305A (en) * 1972-05-25 1975-04-15 Procter & Gamble Fortification of foodstuffs with n-acyl derivatives of sulphur-containing l-amino acids
FR2289179A1 (fr) * 1974-10-28 1976-05-28 Morelle Jean Sels metalliques de lipoaminoacides
US3952115A (en) * 1975-04-02 1976-04-20 The Procter & Gamble Company Fortification of foodstuffs with N-acyl derivatives of sulfur-containing L-amino acid esters
GB2097256B (en) * 1981-04-02 1985-05-30 Morelle Jean V Compositions containing n-butyryl alphaaminoacids
FR2503151A1 (fr) * 1981-04-02 1982-10-08 Morelle Jean Butyryminoacides soufres. mode de preparation. emploi comme element keratogenique chez l'homme et l'animal et comme agent de fertilisation chez les vegetaux
US4827016A (en) * 1985-09-16 1989-05-02 Morgan Lee R Method and compounds for reducing dermal inflammations
US4724239A (en) * 1985-09-16 1988-02-09 Morgan Lee R Method of treating chemical ulcers with N,N'-diacetylcystine, N-acetyl homocysteine and N-acetyl cysteine
US4708965A (en) * 1985-09-16 1987-11-24 Morgan Lee R Method of treating herpes virus infections with N,N'-diacetylcystine and derivatives
JPS62195356A (ja) * 1986-02-20 1987-08-28 Seiwa Kasei:Kk シスチン誘導体及びその塩
IL98310A (en) * 1990-06-08 1996-08-04 Astra Ab Medicinal preparations containing a history of cystine
TW221376B (cs) * 1990-06-28 1994-03-01 Astra Ab
IT1249650B (it) * 1991-05-29 1995-03-09 Poli Ind Chimica Spa N-(5-tioxo-l-prolil)-l-cisteina e suoi derivati, loro preparazione ed impiego terapeutico
SE9103572D0 (sv) * 1991-11-29 1991-11-29 Astra Ab Organic salts of n,n'-diacetyl cystine
EP0746202A4 (en) * 1992-01-06 1997-06-25 Health Maintenance Programs COMPOSITION CONTAINING A PHARMACEUTICALLY ACTIVE ANTI-OXIDANT AND METHOD FOR USE IN THE PREVENTION AND TREATMENT OF RESTENOSIS AFTER ANGIOPLASTY
DE4224670A1 (de) * 1992-07-25 1994-01-27 Boehringer Mannheim Gmbh Verwendung von â,w-Dicarbonsäuren als Fibrinogensenker

Also Published As

Publication number Publication date
WO1996028149A1 (en) 1996-09-19
IL117465A (en) 2000-07-26
IS4554A (is) 1997-08-27
HUP9801985A2 (hu) 1998-12-28
EE9700229A (et) 1998-04-15
IL117465A0 (en) 1996-07-23
NZ303781A (en) 2001-03-30
NO974143D0 (no) 1997-09-09
NO974143L (no) 1997-09-09
CN1183718A (zh) 1998-06-03
CZ280497A3 (cs) 1998-01-14
MX9706825A (es) 1997-11-29
EE03382B1 (et) 2001-04-16
SK282448B6 (sk) 2002-02-05
AU5018596A (en) 1996-10-02
PL183234B1 (pl) 2002-06-28
KR19980703055A (ko) 1998-09-05
AU701287B2 (en) 1999-01-21
SE9500897D0 (sv) 1995-03-14
HUP9801985A3 (en) 2000-07-28
CZ288219B6 (en) 2001-05-16
AR002716A1 (es) 1998-04-29
JPH11501916A (ja) 1999-02-16
CA2214831A1 (en) 1996-09-19
TW385249B (en) 2000-03-21
UA42830C2 (uk) 2001-11-15
PL322328A1 (en) 1998-01-19
US5883126A (en) 1999-03-16
EP0814798A1 (en) 1998-01-07
TR199700945T1 (xx) 1998-02-21
BR9607225A (pt) 1998-07-07
SK120797A3 (en) 1998-02-04

Similar Documents

Publication Publication Date Title
PL322277A1 (en) Derivatives of pyrazol-4-ylobenzoyl
PL311736A1 (en) Derivatives of 1h-imidazoles
PL323066A1 (en) Derivatives of quinazoline
PL313541A1 (en) Derivatives of quinazoline
PL313619A1 (en) Derivatives of piperydine
PL310443A1 (en) Derivatives of pyrolo-pyridine
PL329875A1 (en) Derivatives of carbolin
PL329195A1 (en) Derivatives of 6-phenylpyridol-2-amine
GB9526560D0 (en) Use of 2-Amino-Heterocycles
GB2306473A8 (en) Glucoxide derivatives
PL324451A1 (en) Derivatives of diphenylmethylenepiperidine
PL306127A1 (en) Derivatives of epi-epibathydine
DE59605335D1 (de) Muldenkörper
GB9512290D0 (en) Uses of polyhexanide
HU9600107D0 (en) 9-substituted-2-(2-n-alkoxy-phenyl)-purin-6-one derivatives
PL312692A1 (en) New derivatives of dialkoxy-pyridinol-benzimidazole
ZA96725B (en) Use of phenyclyclohexylcarboxamides
GR3035577T3 (en) Benzisothiazolyl-substituted aminomethylchroman derivatives
EP0810227A4 (en) ISOXAZOLE DERIVATIVES
GR3036572T3 (en) 4-amino-benzoylguanidine derivatives
HK1011013A1 (en) Fluorobenzylether derivatives
ZA961749B (en) The pharmacological use of certain cystine derivatives
IL108595A0 (en) Novel derivatives of tetramethylcyclopropane
GB9516349D0 (en) Aza-anthracyclinone derivatives
ZA964932B (en) New use of pyrrole derivatives